More on Oversight of Direct to Consumer Genetic Testing: Benefits & Harms

More on Oversight of Direct to Consumer Genetic Testing: Benefits & Harms

The FDA is overcautious on consumer genomics, by Robert C Green & Nita A Farahany, Nature News, Jan 15

Two reasons to be overcautious about consumer genomics. By Cecile Janssens

Testing times for the consumer genetics revolution. 
Donna Dickenson, New Scientist, Jan 13, 2014

'DNA tells great stories -- about the past, not future', by Cecile Janssens, Wired, December 2013

Regulation: The FDA is overcautious on consumer genomics : Nature News & Comment